Bio Pharma Dive

MARCH 14, 2023

Responding to policy changes and pressure over high drug costs, the pharma is reducing the sticker price of four branded diabetes medicines by up to 75%.

Insulin 280

Insulin Drugs Branding Medicine 280

Bio Pharma Dive

APRIL 21, 2022

List prices for branded medicines rose by nearly 5% last year, according to IQVIA, a figure that fell to 1% after accounting for rebates and discounts.

Branding 265

Branding Medicine Drugs 265

Bio Pharma Dive

AUGUST 5, 2024

For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical.

Branding 256

Branding Manufacturing Medicine Marketing 256

Bio Pharma Dive

OCTOBER 27, 2020

The startup, which aims to develop lower-cost alternatives to branded medicines, has licensed two drugs from CStone Pharmaceuticals in a deal that could signal a coming price war in cancer immunotherapy.

Licensing 265

Licensing Licensing Drugs Branding 265

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Analysing the world of digitally-native brands highlights three standout ways in which parts of their approach could be brought to the pharmaceutical world. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. The forecast branded NHS drug sales growth figure for 2023 was adjusted to 5.63%. The UK government’s decision to set an unprecedented payback rate of 26.5% billion ($4.1

Sales 243

Sales Branding Drugs Medicine 243

pharmaphorum

NOVEMBER 13, 2020

Offering medicines and healthcare products in a digital capacity through online purchasing and delivery, or via a click-and-collect service, is the perfect solution. Each country has different regulations in regard to the online advertising of prescription drugs and over-the-counter medicines.

Branding 124

Branding Pharmacy Marketing Compliance 124

Pharmaceutical Technology

DECEMBER 15, 2022

Medicines experience a 16% price drop on average post-ATU/early access. GlobalData identified 17 medicines, including eight orphan medicines, that were first available under an early access programme or previous ATU and that are now priced under standard pricing and reimbursement procedures.

Medicine 147

Medicine Marketing Drugs Branding 147

Pharmaceutical Technology

MARCH 17, 2023

Pharmanovia and Aeterna Zentaris have entered an exclusive licensing agreement for the latter’s medicine Ghryvelin (macimorelin). Macimorelin is marketed under the brand name Ghryvelin in the EEA and the UK. The company stated that the new licensing agreement expands its existing endocrinology portfolio.

Hormones 263

Hormones Licensing Licensing Medicine 263

Pharmaceutical Technology

APRIL 12, 2023

Cognizant and Boehringer Ingelheim are collaborating on an integrated cloud platform to enhance the speed and quality of medicinal therapy development. Cognizant will leverage the Veeva Development Cloud platform to help Boehringer Ingelheim to merge medicinal development processes and data into a connected technology ecosystem.

Medicine 130

Medicine Life Science Development Branding 130

Intouch Solutions

SEPTEMBER 14, 2023

Digital medicine is emerging as a revolutionary field that can transform the entire spectrum of healthcare, from proactive prevention to effective treatment of diverse medical conditions. Marketers must position the brand at the intersection of clinical and economic benefits and technology. Download POV

Medicine 105

Medicine Marketing Branding Production 105

pharmaphorum

JULY 5, 2022

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the company last year. Insulin in particular has been singled out by the WHO as being a difficult medicine to access for many people around the world.

Medicine 119

Medicine Insulin Branding Vaccine 119

pharmaphorum

JANUARY 20, 2023

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines. For that, the government has set out the Life Sciences Vision , published back in July 2021.

Medicine 105

Medicine Branding Life Science Production 105

STAT News

NOVEMBER 28, 2022

billion spent by the health care program — on just five medicines during that period, according to a new analysis. By doing so, the company seeks to avoid lawsuits in which the brand-name manufacturer could claim patent infringement. billion from 2015 to 2020 — or nearly 5% of the $30.2

Medicine 105

Medicine Branding Manufacturing Marketing 105

Bio Pharma Dive

OCTOBER 26, 2021

The generic drug unit has struggled in recent years, while Novartis has moved to focus more narrowly on higher-margin branded medicines.

Generic Drugs 164

Generic Drugs Sales Branding Medicine 164

Drug Patent Watch

JANUARY 23, 2025

With the rise of affordable healthcare initiatives and growing demand for quality medicines, emerging markets present a significant opportunity for generic drug manufacturers to expand their reach and improve access to life-saving treatments. However, generic drug development in emerging markets also presents several challenges.

Generic Drugs 85

Generic Drugs Marketing Development Drugs 85

XTalks

DECEMBER 16, 2021

Alternative meat brand Jack & Annie’s, which makes plant-based meat products from jackfruit, recently secured $23 million in a Series B funding round. Co-led by Creadev and Desert Bloom and existing investors Beta Angels and InvestEco, the funding round was the largest to date for the brand. to $7.99.

Branding 90

Branding Production Medicine Marketing 90

Fierce Pharma

SEPTEMBER 14, 2023

. | J&J is uniting its medtech and pharmaceutical arms so that they will be “more connected to the Johnson & Johnson brand," the company said. Over time, Janssen is slated to become Johnson & Johnson Innovate Medicine, while the company’s medical technology segment will continue to run with the J&J MedTech moniker.

Branding 86

Branding Medicine 86

Medical Xpress

DECEMBER 19, 2022

In the competition between brand name pharmaceuticals and their generic counterparts, drug companies use patent gamesmanship to their advantage, one West Virginia University patent expert said.

Branding 72

Branding Medicine Drugs 72

Fierce Pharma

JULY 12, 2023

Two years after it enriched itself with 16 Sanofi drugs, Germany’s Stada Arzneimittel is purchasing another clutch of consumer health brands across multiple European countries.

Branding 69

Branding Medicine Production Drugs 69

Pharmaceutical Technology

NOVEMBER 29, 2022

It is branded as Nubeqa and is already offered on the NHS for patients with localised prostate cancer. The agreement was entered after the UK Medicines and Healthcare products Regulatory Agency (MHRA) granted approval for darolutamide under the global collaboration Project Orbis.

Clinical Trials 296

Clinical Trials Clinical Trials Branding Drugs 296

Pharmaceutical Technology

JUNE 12, 2023

The company is a specialised pharmaceutical wholesaler and holds a licence, issued by the country’s ministry of health, to import non-registered pharmaceutical products, orphan drugs and other life-saving medicines. Lotus Pharmaceuticals CEO Petar Vazharov stated: “We are delighted at our new collaboration with Teraju.

Marketing 242

Marketing Production Branding Manufacturing 242

Fierce Pharma

OCTOBER 17, 2023

working to tweak the Statutory Scheme for branded medicines, the Association of the British Pharmaceutical Industry is making its discontent known—and it’s managed to rally more than 20 major drugmakers to its cause. Even as pharma giants try to get a handle on the Inflation Reduction Act in the U.S., With the U.K.

Branding 78

Branding Drugs Marketing Medicine 78

Pharmaceutical Technology

JULY 13, 2023

GlobalData has analysed HTA decisions made for branded medicines in 5EU from 2018 to 2022, with a focus on oncology.

Branding 130

Branding Medicine Marketing 130

World of DTC Marketing

OCTOBER 21, 2021

SUMMARY: Medicare spent nearly $600 million over a three-year period to pay for four cancer drugs with no clinical benefit an analysis published Monday by JAMA Internal Medicine found.

Clinical Trials 234

Clinical Trials Clinical Trials FDA Approval Trials 234

Pharmaceutical Technology

JULY 25, 2022

As more competitors enter the market, the price of a treatment goes down, explains Stanford University professor of medicine Dr. Kevin Schulman. They are sometimes referred to as hybrid medicines by the European Medicines Agency (EMA). There are significant rebates associated with the sort of branded versions here.”.

Drugs 298

Drugs Manufacturing Production Marketing 298

pharmaphorum

NOVEMBER 16, 2021

In the second of a two-part series, Leela Barham argues that whilst international comparisons of uptake are useful, there could be more to gain from looking at more medicines and their uptake in England rather than looking at a small set of medicines and their uptake internationally. Consistently focus on innovative medicines.

Medicine 96

Medicine Branding Gene Therapy Life Science 96

Drug Patent Watch

JANUARY 14, 2025

Why Generic Drugs Matter Generic drugs are the Robin Hoods of the pharmaceutical world, stealing from the rich (brand-name drugs) and giving to the poor (our wallets). They offer the same therapeutic benefits as their brand-name counterparts but at a fraction of the cost. But how do companies develop these cost-effective alternatives?

Generic Drugs 87

Generic Drugs Development Drugs Manufacturing 87

Fierce Pharma

DECEMBER 20, 2023

. | In a deal worth around $116 million, Novartis is handing over a portfolio of “select ophthalmology brands” to Mumbai’s J.B. plans to distribute and market the medicines in India. Chemicals & Pharmaceuticals. The sale is expected to go into effect in January 2027. Until then, J.B.

Branding 71

Branding Sales Medicine Marketing 71

World of DTC Marketing

AUGUST 29, 2022

A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. Most physicians are trained in medicine and rely on their experiences to understand patients. An integrated approach that ensures a consistency of message(s).

Branding 203

Branding Marketing Pharma Companies Doctor 203

Pharma Marketing Network

DECEMBER 19, 2024

For marketing executives, understanding the significance of leading pharma brands is essential. These brands don’t just sell medications; they cultivate trust, manage reputations, and create value through their strategies. This article explores the leaders in the sector and the trends shaping their future.

Branding 52

Branding Marketing Medicine Production 52

Pharmaceutical Technology

JUNE 29, 2022

The next wave of medicine is well on course to be cell and gene-based. In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295

Pharmaceutical Technology

APRIL 10, 2023

India-based pharmaceutical company Cipla has entered into a perpetual licence agreement with Swiss drugmaker Novartis Pharma for the diabetes drug Galvus and its combination brands. Under the deal, Cipla will be responsible for the manufacturing and marketing of Galvus and its combination brands from 1 January 2026.

Branding 130

Branding Drugs Insulin Production 130

pharmaphorum

NOVEMBER 6, 2024

Get the latest updates on progress with the UK's VPAG (Voluntary scheme for branded medicines Pricing, Access and Growth), including the latest recommendations from the National Institute for Health and Care Excellence (NICE).

Branding 105

Branding Medicine 105

pharmaphorum

FEBRUARY 20, 2024

Learn about the transparency of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) regarding medicines pricing and the Association of the British Pharmaceutical Industry (ABPI). Explore how these factors impact the pharmaceutical industry.

Branding 105

Branding Medicine 105

World of DTC Marketing

NOVEMBER 9, 2021

Digital initiatives are primarily led by growing digital leads with marketing teams not stepping up, relying heavily on brand heritage despite low expectations. Key Finding 7 : A BRAND AND ‘MINE’ FOCUSED MENTALITY. KEY FINDING 6: COLLABORATION AND SHIFT OF POWER IN PHARMA FUNCTIONS The pandemic brought about a real change of power.

Branding 231

Branding Marketing Research Development 231

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharma brands digital presence. Instead of traditional promotional tactics, pharma brands can use educational content to build credibility.

Branding 52

Branding Marketing Compliance Pharma Companies 52